Evidence map›Paper›PMID 40144077›Full record

ArticleMedical science educator2025

Adequacy of Pharmacovigilance Training in the Health Professional Training Institutions in Uganda: Training Gaps and Opportunities for Improvement.

Rajab Kalidi, Henry Kyeyune, Sula Balikuna, Hassan Matovu, Julius Mayengo, Helen Byomire Ndagije

Abstract read
In one paragraph

Article in Medical science educator, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rajab KalidiDepartment of Pharmacy, School of Health Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Henry KyeyuneDepartment of Pharmacy, School of Health Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Sula BalikunaDepartment of Pharmacy, School of Health Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Hassan MatovuDepartment of Pharmacy, School of Health Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
Julius MayengoDirectorate of Product Safety, National Drug Authority, Kampala, Uganda.
Helen Byomire NdagijeDirectorate of Product Safety, National Drug Authority, Kampala, Uganda.ORCID 0000-0001-5802-4791

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Despite efforts to improve pharmacovigilance systems, Uganda's reporting rate remains below the WHO effective reporting criteria of 200 reports per a million inhabitants annually. Adequate education of health science students on pharmacovigilance is one of the core sustainable interventions to improve pharmacovigilance systems. This study assessed the adequacy of pharmacovigilance training in health professional training institutions in Uganda in order to identify the current needs and improvement opportunities. Methods: Data was collected from allied health professional training institutions offering courses in clinical medicine and community health and diploma in pharmacy; universities offering bachelor's degrees in medicine and surgery, pharmacy, nursing and dental surgery; and nursing training institutions offering certificate and diploma courses in nursing and midwifery. The study involved review of 16 curricula and 18 interviews with the heads of the programs of the different institutions. Data on pharmacovigilance content covered in the training curricula, challenges in pharmacovigilance training, pharmacovigilance competencies, knowledge, and skills gaps were collected. The study also included 13 key informants from policy and regulatory bodies, pharmaceutical industry, importers, and distributors of pharmaceuticals, professional councils/societies, examination boards, and hospitals to get perspectives on training gaps and opportunities for improvement. Quantitative data were analysed using Microsoft Excel 2017. Qualitative data were transcribed and reported verbatim. Results: Most of the curricula 15 (88%) had content on medication use problems though inadequate, and only 1 (6%) had content on causality assessment. Majority of the respondents from the training institutions 12 (67%) reported having no staff with subject specific training background on pharmacovigilance. Other challenges reported include the lack of instructional materials and time on their already packed curricular to teach pharmacovigilance. All the respondents from training institutions 18 (100%) and key informants 13 (100%) recommended incorporation of pharmacovigilance into pre-service training curricula as a means of improving pharmacovigilance training and competencies among graduates. According to the key informants, there is need to strengthen pharmacovigilance training in the pre-service curriculum 9 (100%). The knowledge and skills that should be strengthened included detection, management and causality assessment 4 (44%), and spontaneous safety reporting 3 (33%). Conclusions: The curricula for health professional training institutions do not adequately cover content on pharmacovigilance. The key areas that should be strengthened are detection, management and reporting of medication use problems, and causality assessment. Pharmacovigilance content should be introduced and/or strengthened in the existing curricula of all health professional training institutions to meet the growing need for pharmacovigilance experts, create culture of medicine safety and vigilance, and improve patient safety. Supplementary Information: The online version contains supplementary material available at 10.1007/s40670-024-02162-1.

Indexed as

Health professionals trainingPharmacovigilance curriculum

Identifiers

PMID40144077
PMCPMC11933492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.